LEI 969500N3E018961SYA38
HUMAN CELL DESIGN
Contract awards & public grants
Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA → HUMAN CELL DESIGN
European Commission · FR · Grant · 2020-04-16
€38,750
REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc → HUMAN CELL DESIGN
European Commission · FR · Grant · 2016-12-09
€233,717
A Unique Pancreatic Human Beta Cells to revolutionize the Diabetes Drug Discovery → HUMAN CELL DESIGN
European Commission · FR · Grant · 2016-07-15
€50,000
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – → HUMAN CELL DESIGN
European Commission · FR · Grant · 2015-12-07
€373,878
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.